本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

梯瓦製藥

16.19
+0.57003.65%
盤後16.190.0018+0.01%19:52 EDT
成交量:1,192.00萬
成交額:1.92億
市值:185.69億
市盈率:-11.17
高:16.36
開:15.81
低:15.74
收:15.62
資料載入中...
2020/08/05

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/05

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/05

員工持股計劃

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/08/05

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/08/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/05

重要事件披露

8-K - Current report
2020/06/19

SEC問詢函

CORRESP [Cover] - Correspondence
2020/06/09

重要事件披露

8-K - Current report
2020/05/07

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/05/07

重要事件披露

8-K - Current report
2020/02/21

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

重要事件披露

Current report, items 2.02 and 9.01
2020/02/05

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/28

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/25

重要事件披露

Current report, items 1.01, 2.03, and 9.01
2019/11/07

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/07

重要事件披露

Current report, items 5.02 and 9.01
2019/11/07

重要事件披露

Current report, items 2.02 and 9.01
2019/11/06

持股變動聲明

Statement of changes in beneficial ownership of securities